Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Show others and affiliations
2023 (English)In: International Journal of Epidemiology, ISSN 0300-5771, E-ISSN 1464-3685, Vol. 52, no 1, p. 71-86Article in journal (Refereed) Published
Abstract [en]

Background: Previous studies had limited power to assess the associations of circulating insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) with clinically relevant prostate cancer as a primary endpoint, and the association of genetically predicted IGF-I with aggressive prostate cancer is not known. We aimed to investigate the associations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 concentrations with overall, aggressive and early-onset prostate cancer.

Methods: Prospective analysis of biomarkers using the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset (up to 20 studies, 17 009 prostate cancer cases, including 2332 aggressive cases). Odds ratios (OR) and 95% confidence intervals (CI) for prostate cancer were estimated using conditional logistic regression. For IGF-I, two-sample Mendelian randomization (MR) analysis was undertaken using instruments identified using UK Biobank (158 444 men) and outcome data from PRACTICAL (up to 85 554 cases, including 15 167 aggressive cases). Additionally, we used colocalization to rule out confounding by linkage disequilibrium.

Results: In observational analyses, IGF-I was positively associated with risks of overall (OR per 1 SD = 1.09: 95% CI 1.07, 1.11), aggressive (1.09: 1.03, 1.16) and possibly early-onset disease (1.11: 1.00, 1.24); associations were similar in MR analyses (OR per 1 SD = 1.07: 1.00, 1.15; 1.10: 1.01, 1.20; and 1.13; 0.98, 1.30, respectively). Colocalization also indicated a shared signal for IGF-I and prostate cancer (PP4: 99%). Men with higher IGF-II (1.06: 1.02, 1.11) and IGFBP-3 (1.08: 1.04, 1.11) had higher risks of overall prostate cancer, whereas higher IGFBP-1 was associated with a lower risk (0.95: 0.91, 0.99); these associations were attenuated following adjustment for IGF-I.

Conclusions: These findings support the role of IGF-I in the development of prostate cancer, including for aggressive disease.

Place, publisher, year, edition, pages
Oxford University Press, 2023. Vol. 52, no 1, p. 71-86
Keywords [en]
aggressive prostate cancer, Insulin-like growth factor-I, international consortia, Mendelian randomization, prospective analysis, prostate cancer
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-211993DOI: 10.1093/ije/dyac124ISI: 000813479800001PubMedID: 35726641Scopus ID: 2-s2.0-85137773721OAI: oai:DiVA.org:umu-211993DiVA, id: diva2:1782115
Available from: 2023-07-12 Created: 2023-07-12 Last updated: 2024-03-26Bibliographically approved

Open Access in DiVA

fulltext(1205 kB)85 downloads
File information
File name FULLTEXT01.pdfFile size 1205 kBChecksum SHA-512
d03ceeb5ee5bec8571ae617400883e12b328407e5092848261c6f7d3680749e2bc7498a4b6a0e3ea5d9e1be271b0277e42a2d30864fa00e4b6f9c75bb432e4be
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Thysell, Elin

Search in DiVA

By author/editor
Thysell, Elin
By organisation
Pathology
In the same journal
International Journal of Epidemiology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 85 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 368 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf